Literature DB >> 12704221

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Byron Caughey1, Peter T Lansbury.   

Abstract

Many neurodegenerative diseases, including Alzheimer's and Parkinson's and the transmissible spongiform encephalopathies (prion diseases), are characterized at autopsy by neuronal loss and protein aggregates that are typically fibrillar. A convergence of evidence strongly suggests that protein aggregation is neurotoxic and not a product of cell death. However, the identity of the neurotoxic aggregate and the mechanism by which it disables and eventually kills a neuron are unknown. Both biophysical studies aimed at elucidating the precise mechanism of in vitro aggregation and animal modeling studies support the emerging notion that an ordered prefibrillar oligomer, or protofibril, may be responsible for cell death and that the fibrillar form that is typically observed at autopsy may actually be neuroprotective. A subpopulation of protofibrils may function as pathogenic amyloid pores. An analogous mechanism may explain the neurotoxicity of the prion protein; recent data demonstrates that the disease-associated, infectious form of the prion protein differs from the neurotoxic species. This review focuses on recent experimental studies aimed at identification and characterization of the neurotoxic protein aggregates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704221     DOI: 10.1146/annurev.neuro.26.010302.081142

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  535 in total

1.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Alzheimer's therapeutics: translation of preclinical science to clinical drug development.

Authors:  Alena V Savonenko; Tatiana Melnikova; Andrew Hiatt; Tong Li; Paul F Worley; Juan C Troncoso; Phil C Wong; Don L Price
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

3.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

4.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

5.  Probing amyloid fibril growth by two-dimensional near-ultraviolet spectroscopy.

Authors:  Jun Jiang; Shaul Mukamel
Journal:  J Phys Chem B       Date:  2011-04-25       Impact factor: 2.991

6.  Sorting out the driving forces for parallel and antiparallel alignment in the abeta peptide fibril structure.

Authors:  Liming Hou; Michael G Zagorski
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

Review 7.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 8.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

9.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

Review 10.  Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications.

Authors:  Joseph G Moloughney; Noah Weisleder
Journal:  Recent Pat Biotechnol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.